Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 11 - 15 crawled time : 13:00 save search
Medtronic named to the Dow Jones Sustainability World Index
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
MDT | $81.29 0.89% 0.26% 2.1K
|
Health Technology
|
| O: -0.21%
H: 0.08%
C: -1.89%
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RCKT 4 | $23.67 -0.84% -0.7% 450K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -23.94%
disease phase 1 positive trial phase 2 phase 3 rp-a501 danon disease
Rhythm Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide)
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RYTM A | $40.0 2.54% 2.34% 410K
|
Health Technology
|
| O: -0.15%
H: 2.1%
C: -0.68%
new drug fda fda acceptance application setmelanotide drug imcivree
DarioHealth Appoints Seasoned Health Care Executive Jerrod Helms as Chief Commercial Officer
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
DRIO | $1.45 9.85% 13.16% 160K
|
Health Technology
|
| O: -3.18%
H: 1.35%
C: -2.11%
commercialization
Castle Biosciences Named a 2021 Houston Chronicle Top Workplace
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
CSTL | $20.06 2.3% 2.05% 200K
|
Health Technology
|
| O: -2.59%
H: 3.22%
C: 1.57%
bioscience
AlloVir to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
ALVR | $0.7909 3.66% 4.05% 820
|
Health Technology
|
| O: -3.04%
H: 0.0%
C: -2.77%
conference
Repare Therapeutics to Participate in Two Upcoming Virtual Investor Conferences
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RPTX 4 | $3.36 3.07% 3.55% 180K
|
Health Technology
|
| O: 5.3%
H: 0.0%
C: 0.0%
conference therapeutics
Protalix BioTherapeutics Reports Third Quarter 2021 Financial Results and Provides Financial and Business Update
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
PLX | $1.2 1.7% 0.0% 270K
|
Health Services
|
| O: -3.08%
H: 0.0%
C: 0.0%
financial results results iot
Molecular Templates, Inc. Reports Third Quarter 2021 Financial Results
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
MTEM | $1.55 3.33% 3.54% 150
|
Health Technology
|
| O: -0.93%
H: 3.72%
C: 0.56%
financial results results molecular
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -1.32%
H: 2.68%
C: 0.89%
biopharma financial results results
Cybin Inc. Reports its Second Quarter Financial Results and Recent Business Highlights
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
CYBN | $0.355 -1.5% -0.22% 2.8M
|
n/a
|
| O: 1.56%
H: 2.56%
C: -8.21%
financial results results
Biodesix Announces Third Quarter 2021 Results and Highlights
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
BDSX | $1.28 -0.78% -1.18% 37K
|
Health Services
|
| O: -4.45%
H: 5.99%
C: 2.4%
results
Abeona Therapeutics Reports Third Quarter Financial Results
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RGNX | $15.9 1.66% 1.54% 360K
|
Health Technology
|
| O: 2.37%
H: 0.0%
C: 0.0%
ABEO | News | $3.41 -53.67% -116.79% 33K
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: 0.0%
financial results results therapeutics
Palatin Reports First Quarter Fiscal Year 2022 Results and Provides Corporate Update
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
PTN | $1.75 1.74% 0.0% 140K
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
results
GlycoMimetics Completes Enrollment of Phase 3 Registration Trial Evaluating Lead Candidate Uproleselan in Patients with Relapsed /Refractory Acute Myeloid Leukemia (AML)
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
GLYC | $1.835 1.94% 1.91% 540
|
Health Technology
|
| O: 0.47%
H: 2.8%
C: 0.0%
myeloid leukemia leukemia phase 3 trial enroll acute myeloid leukemia aml
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
NVCR | $12.055 1.9% 1.87% 420
|
Health Technology
|
| O: 3.0%
H: 0.39%
C: -3.17%
phase 2 positive results trial topline glioblastoma
Arrowhead Presents New Clinical Data on ARO-APOC3 at AHA 2021
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
ARWR | $23.78 -0.59% -0.61% 830K
|
Health Technology
|
| O: -3.29%
H: 0.86%
C: -10.19%
Gainers vs Losers
| 76% | 24% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
PEGY | $0.0566 23.58% 15.65% 11M
|
Manufacturing
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
BOF | $1.17 6.36% 14.73% 15K
|
LUCY | $0.2545 9.93% 13.94% 66K
|
n/a
PEB 4 | $15.45 2.45% 10.46% 130
|
Finance
MARA | $19.44 10.77% 10.28% 630K
|
Commercial Services
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
Your saved searches
Save your searches and get alerts when important news are released.